Display options
Cite
Jiménez-Osorio AS, González-Reyes S, García-Niño WR, et al. Corrigendum to "Association of Nuclear Factor-Erythroid 2-Related Factor 2, Thioredoxin Interacting Protein, and Heme Oxygenase-1 Gene Polymorphisms with Diabetes and Obesity in Mexican Patients". Oxid Med Cell Longev. 2017;2017:7543194doi: 10.1155/2017/7543194.
Jiménez-Osorio, A. S., González-Reyes, S., García-Niño, W. R., Moreno-Macías, H., Rodríguez-Arellano, M. E., Vargas-Alarcón, G., Zúñiga, J., Barquera, R., Pedraza-Chaverri, J., Meza-Espinoza, J. P., Leal-Ugarte, E., & Peralta-Leal, V. (2017). Corrigendum to "Association of Nuclear Factor-Erythroid 2-Related Factor 2, Thioredoxin Interacting Protein, and Heme Oxygenase-1 Gene Polymorphisms with Diabetes and Obesity in Mexican Patients". Oxidative medicine and cellular longevity, 20177543194. https://doi.org/10.1155/2017/7543194
Jiménez-Osorio, Angélica Saraí, et al. "Corrigendum to "Association of Nuclear Factor-Erythroid 2-Related Factor 2, Thioredoxin Interacting Protein, and Heme Oxygenase-1 Gene Polymorphisms with Diabetes and Obesity in Mexican Patients"." Oxidative medicine and cellular longevity vol. 2017 (2017): 7543194. doi: https://doi.org/10.1155/2017/7543194
Jiménez-Osorio AS, González-Reyes S, García-Niño WR, Moreno-Macías H, Rodríguez-Arellano ME, Vargas-Alarcón G, Zúñiga J, Barquera R, Pedraza-Chaverri J, Meza-Espinoza JP, Leal-Ugarte E, Peralta-Leal V. Corrigendum to "Association of Nuclear Factor-Erythroid 2-Related Factor 2, Thioredoxin Interacting Protein, and Heme Oxygenase-1 Gene Polymorphisms with Diabetes and Obesity in Mexican Patients". Oxid Med Cell Longev. 2017;2017:7543194. doi: 10.1155/2017/7543194. Epub 2017 May 30. PMID: 28642813; PMCID: PMC5468567.
Copy Download .nbib Format: NLM
Share it on

Oxid Med Cell Longev. 2017;2017:7543194. doi: 10.1155/2017/7543194. Epub 2017 May 30.

Corrigendum to "Association of Nuclear Factor-Erythroid 2-Related Factor 2, Thioredoxin Interacting Protein, and Heme Oxygenase-1 Gene Polymorphisms with Diabetes and Obesity in Mexican Patients".

Oxidative medicine and cellular longevity

Angélica Saraí Jiménez-Osorio, Susana González-Reyes, Wylly Ramsés García-Niño, Hortensia Moreno-Macías, Martha Eunice Rodríguez-Arellano, Gilberto Vargas-Alarcón, Joaquín Zúñiga, Rodrigo Barquera, José Pedraza-Chaverri, Juan Pablo Meza-Espinoza, Evelia Leal-Ugarte, Valeria Peralta-Leal

Affiliations

  1. Department of Biology, National Autonomous University of Mexico (UNAM), 04510 Mexico City, DF, Mexico.
  2. Economy Department, Autonomous Metropolitan University-Iztapalapa, 09340 Mexico City, DF, Mexico.
  3. Research Department, Regional Hospital "Lic. Adolfo López Mateos", ISSSTE, 01030 Mexico City, DF, Mexico.
  4. Molecular Biology Department, National Institute of Cardiology "Ignacio Chávez", 14080 Mexico City, DF, Mexico.
  5. Department of Immunology, National Institute of Respiratory Diseases "Ismael Cosío Villegas", 14080 Mexico City, DF, Mexico.
  6. Molecular Genetics Laboratory, National School of Anthropology and History, 14030 Mexico City, DF, Mexico.
  7. Departamento de Genética, Facultad de Medicina e Ingeniería en Sistemas Computacionales de Matamoros, Universidad Autónoma de Tamaulipas, Sendero Nacional km 3, 87349 Matamoros, TAMPS, Mexico.

PMID: 28642813 PMCID: PMC5468567 DOI: 10.1155/2017/7543194

Abstract

[This corrects the article DOI: 10.1155/2016/7367641.].

References

  1. Oxid Med Cell Longev. 2016;2016:7367641 - PubMed

Publication Types